Riddhi Sood

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Improvements in technologies to yield purer circulating tumor cells (CTCs) will enable a broader range of clinical applications. We have previously demonstrated the use of a commercially available cell-adhesion matrix (CAM) assay to capture invasive CTCs (iCTCs). To improve the purity of the isolated iCTCs, here we used fluorescence-activated cell sorting(More)
  • 1